Alphabet Inc (NASDAQ:GOOGL) is Using its Deep Learning Tech To Diagnose Disease

Alphabet Inc (NASDAQ:GOOGL) devised a way to use deep machine learning to teach a neural network how to detect diabetic retinopathy from photos of patients’ eyes. They published their work in the Journal of the American Medical Association on Tuesday. A neural network is kind of like an artificial brain, albeit a simple one. By showing it a huge set of images of patients with and without retina damage, engineers can train the network to distinguish between diseased and non-diseased eyes. After the training, the Google team tested the neural network to see if the algorithm could detect diabetic retinopathy as well as ophthalmologists, who had seen the same images. Alphabet Inc (NASDAQ:GOOGL) traded 1.56 Million shares and was closed at $789.44 per share. The current share price indicates that…


Link to Full Article: Alphabet Inc (NASDAQ:GOOGL) is Using its Deep Learning Tech To Diagnose Disease

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!